IRVINE, Calif., June 27, 2023 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, today announced that it has begun the manufacturing process for the distributable version of its patented transplant technology. A method of checking for signs of graft damage in transplant recipients, the assay measures levels of… Read More..

- Purchase Price 500-800K Shares in PodcastOne at $8 - Adds 24K Subscribers at $8+ ARPU - Expect to be Immediately Accretive Adding $2.5+ Million Revenues and over $600k in EBITDA - PodcastOne Enters Booming Fantasy Sports Market Valued at Over $20 Billion - Brings Fantasy Guru’s 20 Expert Creators… Read More..

DehydraTECH-CBD now featured in eight published, peer-reviewed papers KELOWNA, BC / ACCESSWIRE / June 22, 2023 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces that its groundbreaking research utilizing DehydraTECH-processed cannabidiol ("DehydraTECH-CBD") has now been published in eight peer-reviewed articles in… Read More..